Early radiotherapy cuts disease recurrence:
This article was originally published in Clinica
Executive Summary
Performing radiation therapy early after a prostatectomy in certain patients may reduce the likelihood of prostate cancer recurrence by up to two-thirds. US researchers from the Lahey Clinic in Burlington, Massachusetts, followed 296 patients who underwent a radical prostatectomy for prostate cancer that had spread beyond the prostate capsule. Some 66 patients underwent early adjuvant radiation therapy following the prostatectomy, while the others received hormonal or radiation therapy at the time of disease recurrence. The early radiation group experienced a 12% recurrence rate versus 38% for those in the delayed radiation group.
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.